【identify the causes of progressivism and compare it to populism.】Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in the US
Jan 2 (Reuters) - A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity,identify the causes of progressivism and compare it to populism. according to the U.S. Food and Drug Administration.
The impurity N-Nitrosodiethylamine (NDEA) was detected in quantities above the acceptable limit in certain tablets containing valsartan, the FDA said.
The announcement comes a month after Mylan NV said it will recall all lots of its blood pressure medicines containing valsartan, an angiotensin II receptor blocker, after global health authorities clamped down on the drug.
The health regulator said it will continue to investigate and test all angiotensin II receptor blockers for the presence of NDEA and another probable carcinogen N-nitrosodimethylamine.
In October last year, the FDA halted imports of drug ingredients or medicines containing ingredients produced at a factory of a Chinese bulk manufacturer of valsartan, Zhejiang Huahai Pharmaceuticals.
(Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shinjini Ganguli)
View comments
下一篇:NYSE: REZI Shareholder Notice: Lawsuit against Resideo Technologies, Inc. announced by Shareholders Foundation
相关文章:
- US$4.75 - That's What Analysts Think Century Aluminum Company (NASDAQ:CENX) Is Worth After These Results
- Mitsubishi Motors beats view with 38 percent profit jump on Southeast Asia sales
- Brazil's economy minister to launch pension reform via executive decree -Folha
- Does Cosmo Pharmaceuticals N.V.’s (VTX:COPN) CEO Salary Compare Well With Others?
- Sick of Roaming Fees? Now Your Carrier Is Hurting Too
- Can Triad Group plc (LON:TRD) Maintain Its Strong Returns?
- Boies Schiller Faces $3M Malpractice Suit From Exiled Chinese Billionaire
- BRIEF-Bank Of Guiyang Says Prelim 2018 Net Profit Up 13.4 Percent Y/Y At 5.1 Billion Yuan
- No matter how long you've been at this, your small business is now a startup
- Bulgaria extends bid deadline for Sofia airport tender again
相关推荐:
- 7-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zoom Video Communications, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Fir
- Plaintiffs Get Second Chance in Derivative Case Stemming From California Oil Spill
- What Should Investors Know About Ascott Residence Trust’s (SGX:A68U) Future?
- Trump says U.S. officials to make plea for wall in meeting with lawmakers
- Unum (UNM) Q1 Earnings and Revenues Lag Estimates
- Malaysian palm producer FGV appoints new chief financial officer
- Is the Dollar in for a Surprise? Nonfarm Payrolls and Wage Growth in Focus
- Activision Blizzard plans to terminate CFO Neumann
- Don't Let China Control Your Networks, U.S. Envoy Tells Europe
- Wednesday Newspaper
- Coronavirus spread in Canada is slowing - Public Health Agency
- Recap: eXp World Holdings Q1 Earnings
- Market Sentiment Improves As Investors Pin Hopes on G7 Action
- Is Sirius International Insurance (SG) A Good Stock To Buy Now?
- Glenbriar Announces Agreement to Acquire Kick Pharmaceuticals Inc.
- ETFs Ways to Tap the Rise in Silver Price
- Vaccines Market Worth $62.2 Billion by 2027, Growing at a CAGR of 5.2% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
- Thai Airways rescue plan is its last chance, says PM
- Trex (TREX) Q1 Earnings and Revenues Surpass Estimates
- X-ray Tube Market - Growth, Trends, Forecasts (2020 - 2025)